LCN2 and acute kidney injury: NGAL has now been validated as an early predictive biomarker of AKI in cardiopulmonary bypass (19), kidney transplantation (16,20), diarrhea-associated hemolytic uremic syndrome (21) and contrast nephropathy (22).